Structural analysis of the C-terminal region (modules 18-20) of complement regulator factor H (FH)

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Morgan, Hugh P ^a   Mertens, Haydyn D T ^b   Guariento, Mara ^c,d   Schmidt, Christoph Q ^c,d   Soares, Dinesh C ^a   Svergun, Dmitri I ^b   Herbert, Andrew P ^c   Barlow, Paul N ^c   Hannan, Jonathan P ^a,e  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3B; COMPLEMENT REGULATOR FACTOR H; UNCLASSIFIED DRUG; COMPLEMENT FACTOR H;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; HUMAN; MISSENSE MUTATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; RADIATION SCATTERING; CHEMISTRY; GENETICS; METABOLISM; PROTEIN SECONDARY STRUCTURE; SMALL ANGLE SCATTERING; X RAY CRYSTALLOGRAPHY;

COMPLEMENT FACTOR H; CRYSTALLOGRAPHY, X-RAY; HUMANS; PROTEIN STRUCTURE, SECONDARY; SCATTERING, SMALL ANGLE;

EID: 84857536091     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032187     Document Type: Article

References (64)

1. Schmidt CQ, Herbert AP, Hocking HG, Uhrin D, Barlow PN, (2008) Translational mini-review series on complement factor H: structural and functional correlations for factor H. Clin Exp Immunol 151: 14-24.
2. Kirkitadze MD, Barlow PN, (2001) Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol Rev 180: 146-161.
3. Norman DG, Barlow PN, Baron M, Day AJ, Sim RB, et al. (1991) Three-dimensional structure of a complement control protein module in solution. J Mol Biol 219: 717-725.
4. Ripoche J, Day AJ, Harris TJR, Sim RB, (1988) The complete amino acid sequence of human complement factor H. Biochem J 249: 563-602.
5. Pangburn MK, Schreiber RD, Muller-Eberhard HJ, (1977) Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. J Exp Med 146: 257-270.
6. Weiler JM, Daha MR, Austen KF, Fearon DT, (1976) Control of the amplification convertase of complement by the plasma protein beta1H. Proc Natl Acad Sci U S A 73: 3268-3272.
7. Whaley K, Ruddy S, (1976) Modulation of the alternative complement pathways by beta 1 H globulin. J Exp Med 144: 1147-1163.
8. Meri S, Pangburn MK, (1990) Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci U S A 87: 3982-3986.
9. Meri S, Pangburn MK, (1994) Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H. Biochem Biophys Res Commun 198: 52-59.
10. Pangburn MK, (2000) Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement. Immunopharmacology 49: 149-157.
11. Gordon DL, Kaufman RM, Blackmore TK, Kwong J, Lublin DM, (1995) Identification of complement regulatory domains in human factor H. J Immunol 155: 348-356.
12. Pangburn MK, (2002) Cutting edge: localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome. J Immunol 169: 4702-4706.
13. Schmidt CQ, Herbert AP, Kavanagh D, Gandy C, Fenton CJ, et al. (2008) A new map of glycosaminoglycan and C3b binding sites on factor H. J Immunol 181: 2610-2619.
14. Sharma AK, Pangburn MK, (1996) Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc Natl Acad Sci U S A 93: 10996-11001.
15. Wu J, Wu YQ, Ricklin D, Janssen BJ, Lambris JD, et al. (2009) Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat Immunol 10: 728-733.
16. Pechtl IC, Neely RK, Dryden DTF, Jones AC, Barlow PN, (2011) Use of time-resolved FRET to validate crystal structure of complement regulatory complex between C3b and factor H (N terminus). Protein Sci 12: 2012-2112.
17. Kajander T, Lehtinen MJ, Hyvarinen S, Bhattacharjee A, Leung E, et al. (2011) Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement. Proc Natl Acad Sci U S A 108: 2897-2902.
18. Morgan HP, Schmidt CQ, Guariento M, Blaum BS, Gillespie D, et al. (2011) Structural basis for engagement by complement factor H of C3b on a self surface. Nat Struct Mol Biol 18: 463-470.
19. Blackmore TK, Hellwage J, Sadlon TA, Higgs N, Zipfel PF, et al. (1998) Identification of the second heparin-binding domain in human complement factor H. J Immunol 160: 3342-3348.
20. Blackmore TK, Sadlon TA, Ward HM, Lublin DM, Gordon DL, (1996) Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. J Immunol 157: 5422-5427.
21. Herbert AP, Deakin JA, Schmidt CQ, Blaum BS, Egan C, et al. (2007) Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism. J Biol Chem 282: 18960-18968.
22. Morgan HP, Jiang J, Herbert AP, Kavanagh D, Uhrin D, et al. (2011) Crystallographic determination of the disease-associated T1184R variant of complement regulator factor H. Acta Crystallogr D Biol Crystallogr 67: 593-600.
23. Pangburn MK, Atkinson MA, Meri S, (1991) Localization of the heparin-binding site on complement factor H. J Biol Chem 266: 16847-16853.
24. Prosser BE, Johnson S, Roversi P, Herbert AP, Blaum BS, et al. (2007) Structural basis for complement factor H linked age-related macular degeneration. J Exp Med 204: 2277-2283.
25. Aslam M, Perkins SJ, (2001) Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. J Mol Biol 309: 1117-1138.
26. Fernando AN, Furtado PB, Clark SJ, Gilbert HE, Day AJ, et al. (2007) Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin. J Mol Biol 368: 564-581.
27. Okemefuna AI, Gilbert HE, Griggs KM, Ormsby RJ, Gordon DL, et al. (2008) The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties. J Mol Biol 375: 80-101.
28. Oppermann M, Manuelian T, Jozsi M, Brandt E, Jokiranta TS, et al. (2006) The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein. Clin Exp Immunol 144: 342-352.
29. Schmidt CQ, Herbert AP, Mertens HDT, Guariento M, Soares DC, et al. (2010) The Central Portion of Factor H (Modules 10-15) Is Compact and Contains a Structurally Deviant CCP Module. J Mol Biol 395: 105-122.
30. de Cordoba SR, de Jorge EG, (2008) Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin Exp Immunol 151: 1-13.
31. Boon CJ, Klevering BJ, Hoyng CB, Zonneveld-Vrieling MN, Nabuurs SB, et al. (2008) Basal laminar drusen caused by compound heterozygous variants in the CFH gene. Am J Hum Genet 82: 516-523.
32. Perkins SJ, Goodship TH, (2002) Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site. J Mol Biol 316: 217-224.
33. Raychaudhuri S, Iartchouk O, Chin K, Tan PL, Tai AK, et al. (2011) A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet 43: 1232-1236.
34. Richards A, Buddles MR, Donne RL, Kaplan BS, Kirk E, et al. (2001) Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. Am J Hum Genet 68: 485-490.
35. Saunders RE, Goodship TH, Zipfel PF, Perkins SJ, (2006) An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations. Hum Mutat 27: 21-30.
36. Guigonis V, Fremeaux-Bacchi V, Giraudier S, Favier R, Borderie D, et al. (2005) Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation. Am J Kidney Dis 45: 588-595.
37. Herbert AP, Uhrin D, Lyon M, Pangburn MK, Barlow PN, (2006) Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure. J Biol Chem 281: 16512-16520.
38. Potterton E, Briggs P, Turkenburg M, Dodson E, (2003) A graphical user interface to the CCP4 program suite. Acta Crystallogr D Biol Crystallogr 59: 1131-1137.
39. Evans P, (2006) Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr 62: 72-82.
40. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40: 658-674.
41. Murshudov GN, Vagin AA, Dodson EJ, (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53: 240-255.
42. Terwilliger TC, Grosse-Kunstleve RW, Afonine PV, Moriarty NW, Zwart PH, et al. (2008) Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. Acta Crystallogr D Biol Crystallogr 64: 61-69.
43. Emsley P, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D-Biol Crystallogr 60: 2126-2132.
44. Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, et al. (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35: W375-W383.
45. Maleknia SD, Ralston CY, Brenowitz MD, Downard KM, Chance MR, (2001) Determination of macromolecular folding and structure by synchrotron x-ray radiolysis techniques. Anal Biochem 289: 103-115.
46. Konarev PV, Volkov VV, Sokolova AV, Koch MHJ, Svergun DI, (2003) PRIMUS: a Windows PC-based system for small-angle scattering data analysis. J Appl Crystallogr 36: 1277-1282.
47. Svergun D, Barberato C, Koch MHJ, (1995) CRYSOL- a Program to Evaluate X-ray Solution Scattering of Biological Macromolecules from Atomic Coordinates. J Appl Crystallogr 28: 768-773.
48. Franke D, Svergun DI, (2009) DAMMIF, a program for rapid ab-initio shape determination in small-angle scattering. J Appl Crystallogr 42: 342-346.
49. Volkov VV, Svergun DI, (2003) Uniqueness of ab initio shape determination in small-angle scattering. J Appl Crystallogr 36: 860-864.
50. Kozin MB, Svergun DI, (2001) Automated matching of high- and low-resolution structural models. J Appl Crystallogr 34: 33-41.
51. Petoukhov MV, Svergun DI, (2005) Global rigid body modeling of macromolecular complexes against small-angle scattering data. Biophys J 89: 1237-1250.
52. Bernado P, Mylonas E, Petoukhov MV, Blackledge M, Svergun DI, (2007) Structural characterization of flexible proteins using small-angle X-ray scattering. J Am Chem Soc 129: 5656-5664.
53. Bhattacharjee A, Lehtinen MJ, Kajander T, Goldman A, Jokiranta TS, (2010) Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d. Mol Immunol 47: 1686-1691.
54. Jokiranta TS, Jaakola VP, Lehtinen MJ, Parepalo M, Meri S, et al. (2006) Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. Embo J 25: 1784-1794.
55. Soares DC, Gerloff DL, Syme NR, Coulson AF, Parkinson J, et al. (2005) Large-scale modelling as a route to multiple surface comparisons of the CCP module family. Protein Eng Des Sel 18: 379-388.
56. Kirkitadze MD, Henderson C, Price NC, Kelly SM, Mullin NP, et al. (1999) Central modules of the vaccinia virus complement control protein are not in extensive contact. Biochem J 344 Pt 1: 167-175.
57. Kirkitadze MD, Krych M, Uhrin D, Dryden DT, Smith BO, et al. (1999) Independently melting modules and highly structured intermodular junctions within complement receptor type 1. Biochemistry 38: 7019-7031.
58. Soares DC, Barlow PN, (2005) Complement control protein modules in the regulators of complement activation. In: Morikis D, Lambris JD, editors. Structural Biology of the Complement System Boca Raton CRC Press, Taylor & Francis Group pp. 19-62.
59. Ferreira VP, Herbert AP, Cortes C, McKee KA, Blaum BS, et al. (2009) The Binding of Factor H to a Complex of Physiological Polyanions and C3b on Cells Is Impaired in Atypical Hemolytic Uremic Syndrome. J Immunol 182: 7009-7018.
60. Lehtinen MJ, Rops AL, Isenman DE, van der Vlag J, Jokiranta TS, (2009) Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome. J Biol Chem 284: 15650-15658.
61. Okemefuna AI, Nan R, Miller A, Gor J, Perkins SJ, (2010) Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations. J Biol Chem 285: 1053-1065.
62. Guinier A, (1939) La diffraction des rayons X aux tres petits angles; application a l'etude de phenomenes ultramicroscopiques. Ann Phys (Paris) 12: 161-237.
63. Svergun DI, (1992) Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J Appl Crystallogr 25: 495-503.
64. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA, (2001) Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A 98: 10037-10041.